Assignment of Assignor's Interest

Recorded: 2022-03-11 Pages: 11

Assignor

TARGEGEN, INC.

Executed: 2017-08-16

Assignee

IMPACT BIOMEDICINES, INC.

12526 HIGH BLUFF DRIVE, SUITE 260, SAN DIEGO, CALIFORNIA, 92130

Covered Properties (2)

Compositions and Methods for Treating Myelofibrosis

Application: 16/549,043 →

Publication: US 2019/0381041

Compositions and Methods for Treating Myelofibrosis

Application: 17/220,073 →

Publication: US 2021/0244735

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.